Back
AbbVie Vs. Biogen Industry Stock Comparison
Buy
70
ABBV
AbbVie
Last Price:
$202.13
Seasonality Move:
3.69%
Sell
44
BIIB
Biogen
Last Price:
$140.65
Seasonality Move:
-2.65%
Sell
44
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.78 | Buy |
Relative Strength Index (14 RSI): | 77.27 | Buy |
Chaikin Money Flow: | 248436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (174.59 - 195.65) | Buy |
Bollinger Bands (100): | (173.32 - 194.44) | Buy |
BIIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.72 | Sell |
Relative Strength Index (14 RSI): | 47.08 | Sell |
Chaikin Money Flow: | 1007542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (138.05 - 145.19) | Sell |
Bollinger Bands (100): | (143.05 - 178.35) | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 195.96 | Buy |
20-day SMA: | 188.51 | Buy |
50-day SMA: | 180.71 | Buy |
200-day SMA: | 180.85 | Buy |
8-day EMA: | 196.58 | Buy |
20-day EMA: | 190.38 | Buy |
50-day EMA: | 184.74 | Buy |
200-day EMA: | 179.85 | Buy |
BIIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 137.45 | Buy |
20-day SMA: | 141.56 | Sell |
50-day SMA: | 146.06 | Sell |
200-day SMA: | 188.43 | Sell |
8-day EMA: | 138.59 | Buy |
20-day EMA: | 140.8 | Sell |
50-day EMA: | 147.48 | Sell |
200-day EMA: | 180.35 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.23 per share, an increase this year of $2.10 per share, and an increase next year of $1.57 per share.
Biogen Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.42 per share, a decrease this year of $0.66 per share, and an increase next year of $0.12 per share.
AbbVie Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biogen Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |